Skip to main content
Oncology Letters logoLink to Oncology Letters
. 2010 Nov 10;2(1):123–128. doi: 10.3892/ol.2010.205

Nordihydroguaiaretic acid inhibits growth of cervical cancer SiHa cells by up-regulating p21

PENG GAO 1, FEI ZHAI 1, LEI GUAN 1, JIE ZHENG 1,
PMCID: PMC3412500  PMID: 22870140

Abstract

Nordihydroguaiaretic acid (NDGA) and its derivatives possess anti-cancer effects on various types of cancer via the induction of apoptosis or cell cycle arrest. This study proved that NDGA inhibited cervical cancer SiHa cell growth and induced cell cycle arrest at the G1 phase, which may be a consequence of cell cycle kinase inhibitor p21 induction. NDGA promoted acetylation of histone H3 in total and p21 gene-associated chromatin. This effect is gene selective, since NDGA has no impact on the p27 gene. NDGA also inhibited HPV-16 E6 gene transcription, which in turn resulted in the restoration of p53 protein levels. The silencing mediator for retinoid and thyroid hormone receptors (SMRT) is a key component of the HDAC3-HDAC4-N-CoR/SMRT complex. We found that NDGA significantly inhibited the transcription of SMRT, which, together with p53, may aid in the detection of the increase of histone H3 acetylation within the p21 gene. Our results suggest that NDGA induces p21 transcription by selectively elevating histone H3 acetylation associated with p21 gene and p53 protein levels via the inhibition of HPV-16 E6 expression.

Keywords: nordihydroguaiaretic acid, cervical cancer, histone acetylation, p21, p53

Introduction

Nordihydroguaiaretic acid (NDGA) is a non-specific inhibitor of lipoxygenase. NDGA and its derivatives exhibit anti-cancer effect on various types of cancer, including cervical cancer (13). High-risk human papillomavirus (HPV) infection is strongly associated with cervical cancer. The persistent expression of HPV oncogenes E6 and E7 is crucial for the induction and maintenance of malignant phenotypes (4). HPV E6 and E7 are well-known for their ability to inhibit the activity of tumor suppressors p53 and pRb, respectively (5). Studies have shown that derivatives of NDGA inhibit the growth of cervical cancer cells by stabilizing p53 as a result of down-regulated E6 expression, which may be partially responsible for apoptosis induction or cell cycle arrest at the G1 phase found in NDGA-treated cells (1,6).

p21 is a key mediator of G1/S transition, the expression of which is frequently absent or at low levels in cervical cancer (7), and the restoration of p21 expression suppresses the growth of cervical cancer cells (8,9). It is known that regulation of p21 expression occurs primarily at the transcription level in p53-dependent or p53-independent manners (10) and acetylation of histone H3 within the p21 promoter is also a key event for effective p21 transcription (11,12). With respect to cervical cancer, the results of certain studies showed that the p53 state is correlated with p21 expression (13) and that restoration of p53 function, either by RNAi or drug treatment against HPV E6, induces p21 expression (14,15).

This study aimed to investigate the effect of NDGA on the growth and p21 expression of cervical cancer SiHa cells. Moreover, the effect of NDGA on levels of histone H3 acetylation, p53 protein and other factors was investigated in order to determine the mechanism by which NDGA regulated the p21 gene expression.

Materials and methods

Cell line

The human cervical cancer cell line SiHa was obtained from the Cell Bank of Type Culture Collection of the Chinese Academy of Sciences (Shanghai Institute of Cell Biology, Chinese Academy of Sciences, China), cultured in Dulbecco’s modified Eagle’s medium (DMEM; 4.5 g/l glucose; Invitrogen, Grand Island, NY, USA) supplemented with 10% fetal bovine serum, 100 U/ml penicillin and 100 μg/ml streptomycin in a 5% CO2 incubator at 37°C.

Reagents

NDGA (Sigma-Aldrich, St. Louis, MO, USA) was dissolved in dimethyl sulfoxide (DMSO) and the stock solution was diluted to the required concentrations in DMEM prior to being added to the cell culture medium. Final DMSO concentrations were ≤0.2%. Antibodies against Ac-Histone H3 (Lys 9/14) and β-actin were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). Antibodies against p53 were purchased from Signalway Antibody (Pearland, TX, USA). All other chemicals were of reagent grade.

Cell proliferation assay

Cell proliferation was measured by the MTT assay. SiHa cells were seeded into 96-well culture plates at 5×103 cells per well. Each group consisted of six parallel wells and was subsequently treated with various concentrations of NDGA for 24, 48 and 72 h. The control cells were treated with 2% DMSO in culture medium. Following treatment, the cells were incubated with MTT reagent (0.5 mg/ml) at 37°C for 4 h. The resulting formazan crystals were solubilized by adding 150 μl DMSO to each well. The optical density (OD) at 492 nm was measured and cell viability was determined using the formula: cell viability (%) = (absorbance of the treated wells - absorbance of the blank control wells)/(absorbance of the negative control wells - absorbance of the blank control wells) × 100%. The MTT experiments were repeated at least three times.

Flow cytometry analysis

The cell cycle was analyzed using flow cytometry. Briefly, cells (1×106) were collected and washed twice in phosphate-buffered saline (PBS), then fixed in 70% alcohol for 30 min at 4°C. After being washed in cold PBS three times, the cells were resuspended in 1 ml of PBS solution with 40 μg of propidium iodide (Sigma) and 100 μg of RNase A (Sigma) for 30 min at 37°C. The samples were then analyzed for their DNA content by fluorescence activated cell sorting (BD Immunocytometry Systems, San Jose, CA, USA). Each experiment was repeated at least three times.

Reverse transcriptase -polymerase chain reaction (RT-PCR)

Total RNA was isolated from cells using RNAiso Plus (Takara, Japan) and reverse-transcribed using a reverse transcription system (Promega, Madison, WI, USA) according to the manufacturer’s instructions. PCR amplification of different genes was performed using Easy Taq DNA Polymerase (TransGen Biotech, China). Table I shows the primer sequences used for RT-PCR and the product sizes. GAPDH served as an internal control. The optimal reaction conditions for PCR were determined for each primer pair. Denaturation was at 94°C for 40 sec and annealing at 56°C for 40 sec, followed by elongation at 72°C for 40 sec. PCR products were analyzed by 1.5% agarose/ethidium bromide gel electrophoresis. OD values of mRNA were analyzed with Pro-Gel 4.0 Software and GAPDH was used to normalize mRNA. Each experiment was repeated at least three times.

Table I.

Primer sequences for RT-PCR.

Gene Sense primer (5′-3′) Anti-sense primer (5′-3′) Tm (cycles) Size (bp)
p21 TAGCAGCGGAACAAGGAGTCAG CAGTCTAGGTGGAGAAACGGG 56 (30) 263
SMRT GGAATCACGCTCGGAAACAATG GGCGGTCTTTGTACAACCTTCA 58 (30) 420
GAPDH ACCACAGTCCATGCCATCAC TCCACCACCCTGTTGCTGTA 56 (30) 450

Tm, melting temperature.

Western blot analysis

Nuclear extracts from SiHa cells were prepared using a Nuclear Protein Extraction kit (BestBio, China). The protein concentrations were determined using an Enhanced BCA Protein Assay kit (Beyotime, China). The nuclear proteins (40 μg) were fractionated using sodium dodecyl sulfate-10% polyacrylamide gels for electrophoresis (SDS-PAGE) and the proteins were transferred onto a polyvinylidene fluoride (PVDF) membrane. The membrane was blocked at room temperature for 4 h with 5% bovine serum albumin in Tris-buffered saline containing 0.05% Tween-20, 10 mmol/l Tris-HCl pH 7.5 and 150 mmol/l NaCl, and then incubated with the appropriate primary antibodies overnight at 4°C. Horseradish peroxidase-conjugated anti-goat IgG was used as the secondary antibody, and the protein bands were detected using the enhanced chemiluminescence method. The relative protein levels were normalized to β-actin and expressed as percentages of the control. The membrane was incubated for 30 min at 50°C in buffer that contained 2% SDS, 62.5 mmol/l Tris (pH 6.7) and 100 mmol/l 2-mercaptoethanol. The membrane was then washed and incubated with the other primary antibody.

Chromatin immunoprecipitation (ChIP) assay

ChIP assays were performed using a ChIP Assay kit (Beyotime) according to the manufacturer’s instructions. In brief, SiHa cells were fixed by 1% formaldehyde for 10 min at 37°C. Following washing with cold PBS, the cells were lysed in SDS lysis buffer and sonicated to shear the DNA to an average fragment size of 600 bp. The lysates were cleared by centrifugation and Ac-Histone H3 (Lys 9/14) antibody was added to the supernatants. Immunoprecipitation from soluble chromatin was conducted overnight at 4°C. Immune complexes were collected with protein A+G agarose/salmon sperm DNA for 60 min at 4°C and then extensively washed. The samples were extracted with elution buffer (1% SDS, 0.1 mol/l NaHCO3) and heated at 65°C for 4 h to reverse cross links. The DNA was purified and used for amplification of the p21 or p27 promoter DNA. The primers used for p21 were: forward, 5′-ACCAACGCAGGCGAGGGACT-3′; and reverse, 5′-CCGG CTCCACAAGGAACTGA-3′ (12). The primers used for p27 were: forward, 5′-TGGAGAAGCACTGCAGAGAC-3′; and reverse, 5′-GCGTGTCCTCAGAGTTAGCC-3′ (12). The products were separated by agarose gel electrophoresis and visualized by ethidium bromide staining. Each experiment was repeated at least three times.

Statistical analysis

The quantitative variables are presented as means ± SD. The difference between two groups was assessed using an independent t-test. The differences among ≥3 groups were compared using one-way ANOVA. P<0.05 was considered to be statistically significant.

Results

NDGA inhibited SiHa cell growth and induced cell cycle arrest at G1 phase

The treatment of SiHa cells with various concentrations of NDGA for 24–72 h resulted in cell growth inhibition in a dose- and time-dependent manner (Fig. 1A). A cell cycle assay was performed and it was found that cell cycle progression of SiHa cells was significantly inhibited at the G1 phase. As shown in Fig. 1B, the SiHa cells showed a higher proportion of cells at the G1 phase and a decrease in the proportion of cells at the G2 phase, compared to the control cells. Cell cycle distribution analysis showed that the increase in G1-phase cells observed in SiHa was significant (P<0.05) and the induction of cell cycle arrest was dose-dependent. These results demonstrated that NDGA substantially inhibited the proliferation of SiHa cells and induced G1 phase arrest in vitro.

Figure 1.

Figure 1

(A) Effects of NDGA on the growth of SiHa cells by MTT assay. (B) Effects of NDGA on the cell cycle of SiHa cells by flow cytometry. (C) NDGA up-regulated the mRNA levels of p21 by RT-PCR. The relative levels of mRNA normalized with GAPDH are shown. *P<0.05, relative to control.

NDGA induced cell cycle arrest by up-regulating p21

To determine the mechanisms of NDGA-induced cell cycle arrest, the effect of NDGA on the expression of p21, a key mediator of G1/S transition, was examined. It was found that NDGA treatment for 72 h significantly increased the levels of p21 mRNA (Fig. 1C) by up to nearly 2-fold.

NDGA induced accumulation of acetylated histone H3

The level of histone H3 acetylation was determined at Lys 9 and 14 in SiHa cells treated with NDGA. Nucleic proteins were isolated from cells treated with NDGA (80 μmol/l) for 72 h. Cells were treated with histone deacetylase inhibitor (HDACi) trichostatin A (TSA) (300 nmol/l) as a positive control. Western blot analysis showed that prior to incubation with NDGA, the level of acetylated histone H3 in SiHa cell was low (Fig. 2A). Incubation with NDGA for 72 h resulted in the accumulation of acetylated histone H3.

Figure 2.

Figure 2

NDGA clearly increased the acetylation levels of (A) global histone H3 and (B) histone H3 associated with p21 promoter in SiHa cells. (A) Protein levels of acetylated histone H3 (Lys 9/14) were measured by Western blotting. The relative levels of acetylated histone H3 were normalized with β-actin. (B) Acetylation level of histone H3 (Lys 9/14) associated with p21 promoter was measured by ChIP. (C) NDGA inhibited SMRT expression by RT-PCR. SiHa cells were treated with various NDGA concentrations for 72 h. The relative levels of SMRT mRNA were normalized with GAPDH. *P<0.05, relative to control.

The effect of NDGA on the acetylation of histone H3 associated with the p21 gene promoter was examined by ChIP. Chromatin fragments from cells cultured with and without NDGA (80 μmol/l) for 72 h were immunoprecipitated with an antibody against acetylated histone H3 at Lys 9 and Lys 14. DNA from the immunoprecipitated DNA-protein complex was isolated. From this DNA, a 324-bp fragment of the p21 promoter region was amplified. In the control, the acetylated histone H3 was nearly undetectable. After treatment with NDGA, we observed a significant increase in acetylated histone H3 within p21 promoter (Fig. 2B).

NDGA down-regulated silencing mediator for retinoid and thyroid hormone receptors (SMRT) level

To determine the mechanism by which NDGA induced histone H3 acetylation, the effect of NDGA on SMRT transcription was detected. The results showed that NDGA inhibited the SMRT mRNA level in a dose-dependent manner (Fig. 2C).

NDGA had no effect on the acetylation of histones H3 in chromatin associated with p27 gene

To determine whether this effect was selective for a limited number of genes, the level of histone H3 acetylation in the p27 gene was examined. The expression of p27 mRNA increased no more than doubled, while the p27 protein level up-regulated significantly (Fig. 3A and B). No change in the levels of histone H3 acetylation was detected following treatment with NDGA (Fig. 3C). The results suggest that the NDGA-induced changes in histone acetylation were localized to specific areas of the chromatin.

Figure 3.

Figure 3

Effects of NDGA on p27 expression. SiHa cells were treated with various NDGA concentrations for 72 h. (A) Effect of NDGA on the expression of p27 mRNA by RT-PCR. (B) Effect of NDGA on the expression of p27 protein by Western blotting. (C) NDGA had no effect on histone H3 acetylation associated with the p27 gene. SiHa cells were treated with 80 μmol/l NDGA for 72 h. TSA served as a positive control. The acetylation level of histone H3 associated with the p27 promoter was measured by ChIP.

NDGA restored the protein level of p53 by inhibiting HPV16 E6 expression

The effect of NDGA on the protein level of p53, a tumor suppressor which is also a critical regulator of p21 transcription, was detected. The results showed that NDGA elevated the p53 protein level in a dose-dependent manner (Fig. 4A). The effect of NDGA and TSA on the transcription of HPV16 E6, which induces degradation of p53 was also investigated. As2O3 was used as a positive control, as it inhibits the expression of HPV16 E6/E7 (16). The results showed that NDGA significantly inhibited the HPV16 E6 mRNA level in a dose-dependent manner (Fig. 4B and C), whereas TSA had no such effect.

Figure 4.

Figure 4

Effects of NDGA treatment on the p53 protein levels and HPV-16 E6 mRNA levels. (A) NDGA increased the p53 protein levels in a dose-dependent manner. SiHa cells were treated with increasing amounts of NDGA for 72 h. p53 expression was examined by Western blotting. The relative levels of the p53 protein were normalized with β-actin. *P<0.05, relative to control. (B and C) NDGA inhibited the mRNA level of HPV-16 E6 by RT-PCR.

Discussion

NDGA and its derivatives are potentially useful drugs due to their significant inhibitory effects on various types of cancer. However, detailed mechanisms that underlie their anti-cancer roles remain unclear. For this reason, we studied the effect of NDGA on the growth of cervical cancer SiHa cells and its mechanism. We found that NDGA treatment significantly inhibited the growth of SiHa cells and induced cell cycle arrest at the G1 phase, which may be a result of the up- regulation of p21, a key mediator of G1/S transition. Based on these observations, we studied the effect of NDGA on the p53 protein level and histone H3 acetylation, two key factors for p21 transcription (10).

In cervical cancer cells, HPV E6 abrogates p53 function (5) and the restoration of p53 activity in SiHa cells increases p21 mRNA (14,17). As with 3-O-methyl-NDGA, a derivative of NDGA (1), we found that NDGA stabilizes p53 protein by suppressing HPV-16 E6 expression. p53 forms a complex with Sp1 and simultaneously dissociates HDAC1 from the C terminus of Sp1, which, in turn, induces p21 expression (18). Moreover, since HPV E6 and E7 are expressed as bicistronic mRNA, the restoration of p53 function may be a result of down-regulated HPV E7, the silencing of which decreases histone deacetylase SIRT1 in SiHa cells (19). Reciprocal regulation occurs between SIRT1 and p53 in which SIRT1 binds and de-acetylates activated p53 (20), whereas activated p53 down-regulates SIRT1 translation via miR-34a (21).

For the first time, we found that NDGA promoted the acetylation of histone H3 in total and p21 gene-associated chromatin, with the latter effect being gene selective, since NDGA has no impact on the p27 gene. However, NDGA promoted the levels of p27 mRNA and particularly that of p27 protein, which, together with p21 and p53, contribute to NDGA-induced cell cycle arrest. It is already established that acetylation at K9 and K14 of histone H3 is associated with the relaxation of chromatin for transcription (22), whereas the acetylation levels at these sites were very low in the SiHa cells (19,23). Although wild-type p53 does not induce acetylation at K9 and K14 of histone H3 (24), it was reported that the presence of p53 likely inhibits K9 deacetylation and facilitates K14 acetylation in response to UV irradiation (23). Therefore, other mechanisms exist by which NDGA induces histone H3 acetylation.

The histone acetylation state is affected by the balance between histone deacetylases (HDACs) and histone acetyl transferases (HATs), both of which have various members (25). Of the numerous HATs that exist, p300 plays a crucial role in the regulation of p21 expression (26). However, in SiHa cells p300 loses function for mutation (27). A review of the literature showed that HDAC3-HDAC4-N-CoR/SMRT is a complex that plays a critical role in the regulation of histone acetylation associated with the p21 promoter, as HDAC4 or SMRT down-regulation results in increased histone H3 acetylation at the proximal p21 promoter (28). Our preliminary result proved that NDGA significantly down-regulated SMRT transcription. However, whether NDGA affects other components of this complex remains to be determined.

In conclusion, our results suggest that NDGA induces p21 transcription by selectively elevating histone H3 acetylation associated with p21 gene and p53 protein levels via inhibition of HPV-16 E6 expression.

Acknowledgements

This study was supported by the Scientific Research Foundation of the Graduate School of Southeast University, P.R. China (No. YBJJ0915).

References

  • 1.Allen KL, Tschantz DR, Awad KS, Lynch WP, DeLucia AL. A plant lignan, 3′-O-methyl-nordihydroguaiaretic acid, suppresses papillomavirus E6 protein function, stabilizes p53 protein, and induces apoptosis in cervical tumor cells. Mol Carcinog. 2007;46:564–575. doi: 10.1002/mc.20305. [DOI] [PubMed] [Google Scholar]
  • 2.Meyer GE, Chesler L, Liu D, Gable K, Maddux BA, Goldenberg DD, Youngren JF, Goldfine ID, Weiss WA, Matthay KK, Rosenthal SM. Nordihydroguaiaretic acid inhibits insulin-like growth factor signaling, growth, and survival in human neuroblastoma cells. J Cell Biochem. 2007;102:1529–1541. doi: 10.1002/jcb.21373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Meyers RO, Lambert JD, Hajicek N, Pourpak A, Kalaitzis JA, Dorr RT. Synthesis, characterization, and anti-melanoma activity of tetra-O-substituted analogs of nordihydroguaiaretic acid. Bioorg Med Chem Lett. 2009;19:4752–4755. doi: 10.1016/j.bmcl.2009.06.063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Zur Hausen H. Papillomavirus infections – a major cause of human cancers. Biochim Biophys Acta. 1996;1288:F55–F78. doi: 10.1016/0304-419x(96)00020-0. [DOI] [PubMed] [Google Scholar]
  • 5.Narisawa-Saito M, Kiyono T. Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins. Cancer Sci. 2007;98:1505–1511. doi: 10.1111/j.1349-7006.2007.00546.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Zhao J, Zhao Y, Chen W, Li YM, Bian XW. The differentiation- inducing effect of Nordy on HPV-16 subgenes-immortalized human endocervical cells H8. Anticancer Drugs. 2008;19:713–719. doi: 10.1097/CAD.0b013e3283081ac8. [DOI] [PubMed] [Google Scholar]
  • 7.Bahnassy AA, Zekri AR, Alam El-Din HM, Aboubakr AA, Kamel K, El-Sabah MT, Mokhtar NM. The role of cyclins and cyclins inhibitors in the multistep process of HPV-associated cervical carcinoma. J Egypt Natl Canc Inst. 2006;18:292–302. [PubMed] [Google Scholar]
  • 8.Tsao YP, Huang SJ, Chang JL, Hsieh JT, Pong RC, Chen SL. Adenovirus-mediated p21(WAF1/SDII/CIP1) gene transfer induces apoptosis of human cervical cancer cell lines. J Virol. 1999;73:4983–4990. doi: 10.1128/jvi.73.6.4983-4990.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Hirano K, Hirano M, Zeng Y, Nishimura J, Hara K, Muta K, Nawata H, Kanaide H. Cloning and functional expression of a degradation-resistant novel isoform of p27Kip1. Biochem J. 2001;353:51–57. [PMC free article] [PubMed] [Google Scholar]
  • 10.Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer. 2009;9:400–414. doi: 10.1038/nrc2657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Chen YX, Fang JY, Lu R, Qiu DK. Expression of p21(WAF1) is related to acetylation of histone H3 in total chromatin in human colorectal cancer. World J Gastroenterol. 2007;13:2209–2213. doi: 10.3748/wjg.v13.i15.2209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Richon VM, Sandhoff TW, Rifkind RA, Marks PA. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation. Proc Natl Acad Sci USA. 2000;97:10014–10019. doi: 10.1073/pnas.180316197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Giannoudis A, Herrington CS. Differential expression of p53 and p21 in low grade cervical squamous intraepithelial lesions infected with low, intermediate, and high risk human papillomaviruses. Cancer. 2000;89:1300–1307. doi: 10.1002/1097-0142(20000915)89:6<1300::aid-cncr15>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  • 14.Hietanen S, Lain S, Krausz E, Blattner C, Lane DP. Activation of p53 in cervical carcinoma cells by small molecules. Proc Natl Acad Sci USA. 2000;97:8501–8506. doi: 10.1073/pnas.97.15.8501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.De-Castro Arce J, Göckel-Krzikalla E, Rösl F. Retinoic acid receptor beta silences human papillomavirus-18 oncogene expression by induction of de novo methylation and heterochromatinization of the viral control region. J Biol Chem. 2007;282:28520–28529. doi: 10.1074/jbc.M702870200. [DOI] [PubMed] [Google Scholar]
  • 16.Deng Y, Lin C, Zheng J, Fu M, Liang X, Chen J, Xiao P, Wu M. Overexpression of Bcl-2 partly inhibits apoptosis of human cervical cancer SiHa cells induced by arsenic trioxide. Chin Med J (In English) 2000;113:84–88. [PubMed] [Google Scholar]
  • 17.Yoshinouchi M, Yamada T, Kizaki M, Fen J, Koseki T, Ikeda Y, Nishihara T, Yamato K. In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by E6 siRNA. Mol Ther. 2003;8:762–768. doi: 10.1016/j.ymthe.2003.08.004. [DOI] [PubMed] [Google Scholar]
  • 18.Lagger G, Doetzlhofer A, Schuettengruber B, Haidweger E, Simboeck E, Tischler J, Chiocca S, Suske G, Rotheneder H, Wintersberger E, Seiser C. The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene. Mol Cell Biol. 2003;23:2669–2679. doi: 10.1128/MCB.23.8.2669-2679.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Allison SJ, Jiang M, Milner J. Oncogenic viral protein HPV E7 up-regulates the SIRT1 longevity protein in human cervical cancer cells. Aging. 2009;1:316–327. doi: 10.18632/aging.100028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK, Guarente L, Weinberg RA. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell. 2001;107:149–159. doi: 10.1016/s0092-8674(01)00527-x. [DOI] [PubMed] [Google Scholar]
  • 21.Yamakuchi M, Ferlito M, Lowenstein CJ. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci USA. 2008;105:13421–13426. doi: 10.1073/pnas.0801613105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Jenuwein T, Allis CD. Translating the histone code. Science. 2001;293:1074–1080. doi: 10.1126/science.1063127. [DOI] [PubMed] [Google Scholar]
  • 23.Allison SJ, Milner J. Loss of p53 has site-specific effects on histone H3 modification, including serine 10 phosphorylation important for maintenance of ploidy. Cancer Res. 2003;63:6674–6679. [PubMed] [Google Scholar]
  • 24.Warnock LJ, Adamson R, Lynch CJ, Milner J. Crosstalk between site-specific modifications on p53 and histone H3. Oncogene. 2008;27:1639–1644. doi: 10.1038/sj.onc.1210787. [DOI] [PubMed] [Google Scholar]
  • 25.Eberharter A, Becker PB. Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics. EMBO Rep. 2002;3:224–229. doi: 10.1093/embo-reports/kvf053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Xiao H, Hasegawa T, Isobe K. p300 collaborates with Sp1 and Sp3 in p21(waf1/cip1) promoter activation induced by histone deacetylase inhibitor. J Biol Chem. 2000;275:1371–1376. doi: 10.1074/jbc.275.2.1371. [DOI] [PubMed] [Google Scholar]
  • 27.Ohshima T, Suganuma T, Ikeda M. A novel mutation lacking the bromodomain of the transcriptional coactivator p300 in the SiHa cervical carcinoma cell line. Biochem Biophys Res Commun. 2001;281:569–575. doi: 10.1006/bbrc.2001.4389. [DOI] [PubMed] [Google Scholar]
  • 28.Wilson AJ, Byun DS, Nasser S, Murray LB, Ayyanar K, Arango D, Figueroa M, Melnick A, Kao GD, Augenlicht LH, Mariadason JM. HDAC4 promotes growth of colon cancer cells via repression of p21. Mol Biol Cell. 2008;19:4062–4075. doi: 10.1091/mbc.E08-02-0139. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Oncology Letters are provided here courtesy of Spandidos Publications

RESOURCES